Skip to main content
James Markert, MD, Neurosurgery, Birmingham, AL, University of Alabama Hospital

JamesMMarkertMD

Neurosurgery Birmingham, AL

Brain & Spinal Tumor

Professor of Neurological Surgery, University Alabama

Dr. Markert is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Markert's full profile

Already have an account?

Summary

  • Chair, Department of Neurosurgery

Education & Training

  • University of Michigan Health System
    University of Michigan Health SystemResidency, Neurological Surgery, 1988 - 1995
  • Columbia University Vagelos College of Physicians and Surgeons
    Columbia University Vagelos College of Physicians and SurgeonsClass of 1988

Certifications & Licensure

  • AL State Medical License
    AL State Medical License 1995 - 2022
  • American Board of Neurological Surgery Neurological Surgery

Awards, Honors, & Recognition

  • Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
  • Fellow (FAANS) American Association of Neurological Surgeons
  • Fellow (FACS) American College of Surgeons
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Original Article Stereotactic Placement of Intratumoral Catheters for Continuous Infusion Delivery of HSV-1 G207 in Pediatric Malignant Supratentorial Brain Tumors  
    Asim K Bag, G Yancey Gillespie, Gregory K Friedman, Zachary Wright, James M Markert, James M Johnston, ScienceDirect

Lectures

  • 63rd Southern Neurosurgical Society Annual Meeting Presidential Address 
    Southern Neurosurgical Society, Amelia Island, Florida - 3/28/2012

Authored Content

  • Clinical Utility of Serum Procalcitonin Level and Infection in the Neurosurgical Intensive Care UnitJanuary 2018
  • Clinical Utility of Serum Procalcitonin Level and Infection in the Neurosurgical Intensive Care UnitJanuary 2018

Press Mentions

  • Viral Therapy Shows Promise Against Brain Tumors
    Viral Therapy Shows Promise Against Brain TumorsApril 8th, 2014
  • Brain Tumors: Still Devastating, but Treatment Has Come a Long Way
    Brain Tumors: Still Devastating, but Treatment Has Come a Long WayJune 19th, 2017
  • Mustang Bio and Nationwide Children’s Hospital Receive Orphan Drug Designation for MB-108 (Oncolytic Virus C134) for the Treatment of Malignant Glioma
    Mustang Bio and Nationwide Children’s Hospital Receive Orphan Drug Designation for MB-108 (Oncolytic Virus C134) for the Treatment of Malignant GliomaMay 16th, 2019
  • Join now to see all

Grant Support

  • Lessons From The OR: Using Clinical Biologic Correlates To Inform HSV TrialNational Cancer Institute2009–2011
  • CT 2001 A Staged Phase I Study Of The Treatment Of Malignant Glioma With G207,National Center For Research Resources2006–2007
  • Genetically Engineered HSV 1 In Malignant GliomaNational Center For Research Resources1999–2002
  • Engineered Herpes Simplex Virus For Treatment Of GliomasNational Institute Of Neurological Disorders And Stroke1997–2001

Professional Memberships

Hospital Affiliations